Assetmark Inc. lifted its holdings in shares of Centene Co. (NYSE:CNC – Free Report) by 193.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,640 shares of the company’s stock after acquiring an additional 2,398 shares during the quarter. Assetmark Inc.’s holdings in Centene were worth $274,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Swedbank AB acquired a new position in shares of Centene during the first quarter worth about $914,080,000. Capital International Investors boosted its holdings in Centene by 60.2% in the 1st quarter. Capital International Investors now owns 5,216,486 shares of the company’s stock worth $409,390,000 after acquiring an additional 1,959,460 shares during the period. AQR Capital Management LLC raised its stake in shares of Centene by 22.9% during the second quarter. AQR Capital Management LLC now owns 4,461,517 shares of the company’s stock valued at $295,799,000 after purchasing an additional 832,318 shares during the period. Legal & General Group Plc lifted its position in shares of Centene by 14.2% during the second quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock worth $339,042,000 after purchasing an additional 636,683 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its holdings in Centene by 42.3% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 1,400,276 shares of the company’s stock valued at $92,838,000 after purchasing an additional 416,003 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, CFO Andrew Lynn Asher purchased 17,200 shares of the company’s stock in a transaction on Wednesday, November 13th. The shares were bought at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the purchase, the chief financial officer now owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sarah London acquired 4,117 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.33% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on CNC
Centene Stock Down 2.1 %
NYSE:CNC opened at $57.46 on Friday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The stock has a 50 day moving average of $68.06 and a 200-day moving average of $71.01. The firm has a market capitalization of $29.01 billion, a PE ratio of 9.98, a price-to-earnings-growth ratio of 0.80 and a beta of 0.49. Centene Co. has a 52 week low of $57.25 and a 52 week high of $81.42.
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- Manufacturing Stocks Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Basic Materials Stocks Investing
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Transportation Stocks Investing
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.